Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Thalamofrontal synaptic weakening underlies short-term memory deficits from adolescent NMDAR hypofunction

AI Summary
  • Adolescent NMDAR antagonism with ketamine causes STM deficits by impairing mediodorsal thalamus to dorsomedial prefrontal cortex synaptic transmission.
  • Projection-specific presynaptic impairments: reduced release probability and attenuated short-term depression at MD to dmPFC synapses, without corticocortical or excitability changes.
  • Chemogenetic strengthening of MD to dmPFC projections restores direction-selective coding and delayed alternation performance, identifying TF synapses as therapeutic targets.
Summarise with AI (MRCPsych/FRANZCP)

Sci Adv. 2026 Sep 25;12(39):eaee2152. doi: 10.1126/sciadv.aee2152. Epub 2026 Sep 23.

ABSTRACT

Thalamofrontal (TF) dysconnectivity is one of the most consistent circuit-level abnormalities reported in patients with schizophrenia and is linked to deficits in short-term memory (STM). However, the biological mechanisms underlying TF weakening remain unclear. Here, we show that repeated adolescent N-methyl-d-aspartate receptor (NMDAR) antagonism produces STM deficits by impairing TF synaptic transmission. In mice repeatedly exposed to ketamine, STM impairment coincided with reduced release probability and attenuated short-term depression at mediodorsal thalamus (MD) → dorsomedial prefrontal cortex (dmPFC) synapses, without detectable changes in corticocortical synaptic release probability, intrinsic excitability, or gross synaptic ultrastructure. These presynaptic deficits were accompanied by diminished direction-selective population coding in the dmPFC and impaired delayed alternation performance. Chemogenetically strengthening MD → dmPFC projections restored both neural selectivity and behavior. These findings identify a projection-specific presynaptic mechanism through which adolescent NMDAR hypofunction weakens TF communication and produces cognitive impairment, offering a biological explanation for clinically observed TF dysconnectivity and establishing TF synapses as a therapeutic target.

PMID:42777060 | DOI:10.1126/sciadv.aee2152

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD